Menu
Peptide Database
Results
No peptides found
Featured

Use search to browse all 100+ peptides

Thymosin-alpha-1

Thymalfasin, Zadaxin, Thymosin α1

Quick Stats
Studies 759
Trials 63
Score 2
1990 pubmed

Phytohemagglutin-stimulated human T cell: prothymosin alpha as an accessory signal.

Cordero. O J OJ; Sarandeses. C S CS; Nogueira. M M

Key Findings

  • Thymosin‑alpha‑1 and prothymosin‑alpha enhance T‑cell proliferation only under certain stimulation levels, doses, and pre‑incubation times
  • Monocytes or their secreted factors are needed for the peptide‑driven proliferation, and IL‑1 can boost the effect
  • Blocking the IL‑2 receptor stops the proliferation, indicating the response relies on an IL‑2‑dependent pathway

Practical Outcomes

  • For DIY health enthusiasts, simply taking thymosin‑alpha‑1 isn’t likely to boost immunity on its own; it works best when the immune system is already activated and in the presence of other signals like monocyte‑derived factors or IL‑1. Without careful timing, dosing, and possibly co‑stimulation, the peptide’s benefits may be limited, so it isn’t ready for a straightforward supplementation protocol yet.

Summary

The study shows that thymosin‑alpha‑1 (and a related protein, prothymosin‑alpha) can boost T‑cell growth, but only when immune cells are already activated and when other immune helpers like monocytes or IL‑1 are present. It also reveals that the effect depends on the IL‑2 pathway, and a similar peptide (thymosin‑beta‑4) does nothing, so it can be used as a control.

Abstract

Thymic peptide factors are known to modulate proliferation of normal human lymphocytes. In this work, we studied the effect of Prothymosin alpha (Pro alpha) on PHA-stimulated PBMC and PBLC. The observed effects of Pro alpha and thymosin alpha 1 (alpha 1) on PBMC were found to depend on the degree of cell stimulation, dose, and preincubation-time. Thymosin beta 4 (beta 4) had no effect on either cell type, regardless of the degree of stimulation, which shows that beta 4 may be used as a control peptide to work in this area. Induction of lymphoproliferation also depended on the presence of macrophages. Addition of monocytes or a cell-free monocyte culture supernatant (not containing IL-2) to the PHA-stimulated PBLC cultures resulted in T cell proliferation. Although IL-1 could not restore the PHA-induced proliferative response of isolated T cells by itself, it would enhance the helper effect of Pro alpha. Moreover, a polyclonal goat anti-human IL-2R (Tac Ag) did block the proliferative response induced by combined rIL-1 and Pro alpha, suggesting that an IL-2-dependent pathway of T cell proliferation was involved.

Study Information

Provider

pubmed

Year

1990